Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, 730000, China
NCT Number: NCT04413526
In this retrospective study, the investigators assessed the application of radiofrequency-assisted liver resection in intractable liver cancer resection, and plan to analysis the different factors.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Lanzhou, Gansu, 730000, China
The primary clinical treatment of liver cancer is surgical resection, although many integrated applications develop rapidly, surgery is still the best way to remove the tumour lesion. Traditional ways that have curative removed tumours in three methods, which are liver resection, liver transplantation and radiofrequency ablation (RFA).
As for primary liver cancer, surgery, and RFA are both effective and safety, but for the complexity of end-stage liver cancer, surgical resection may not remove the tumours alone. Surgical resection with radiofrequency ablation therapy for intractable liver cancer is a kind of active plan. The therapy can eliminate the tumour, maximize the protection of patient liver tissue, reduce operation damage, reduce the incidence of complications, and improve patients quality of life after surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
radiofrequency combined with liver resection
only TACE treatment
TACE followed by radiofrequency
Time frame: 5 years
The survival rates was defined as the percentage of liver cancer for five years.
Time frame: 3 months
The length of stay in a hospital regarding days
Time frame: 3 months
The Child-Pugh is based on the presence and severity of ascites and hepatic encephalopathy, the prolongation of prothrombin time, and the levels of serum bilirubin and albumin. According to the Child-Pugh scores, patients are classified into three classes (Child class A, B, and C with CP scores 5-6, 7-9, and 10-15, respectively)
Hepatopancreatobiliary Surgery Institute of Gansu Province
Other
The Application of Radiofrequency-assisted Liver Resection in Intractable Liver Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05128032
Adenocarcinoma, Carcinoma
Boston, Massachusetts, United States
View Trial DetailsNCT01387555
Adenocarcinoma, Carcinoma
La Jolla, California, United States
View Trial DetailsNCT05964361
Adnexal Diseases, Digestive System Diseases
Edegem, Belgium
View Trial DetailsNCT04597710
Digestive System Diseases, Digestive System Neoplasms
Basingstoke, Hampshire, United Kingdom
View Trial Details